SU552085A1 - Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis - Google Patents
Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesisInfo
- Publication number
- SU552085A1 SU552085A1 SU1166638A SU1166638A SU552085A1 SU 552085 A1 SU552085 A1 SU 552085A1 SU 1166638 A SU1166638 A SU 1166638A SU 1166638 A SU1166638 A SU 1166638A SU 552085 A1 SU552085 A1 SU 552085A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- erythrophosphatid
- blood coagulation
- treatment
- hemopoiesis
- medication
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Эритрофосфатид в концентрации 6,25- 25 мг.% нормализирует свертывающую систему крови больных с симптомокомплексом Верльгофа.Erythrophosphatide at a concentration of 6.25-25 mg.% Normalizes the blood coagulation system of patients with the Verlgoth symptom complex.
Кроме того, Эритрофосфатид стимулирует гемопоэзическую функцию организма и оказывает противоаллергическое действие, что имеет существенное значение при лечении геморрагических диатезов, особенно иммунологического происхождени .In addition, Erythrophosphatid stimulates the hematopoietic function of the body and has antiallergic effect, which is essential in the treatment of hemorrhagic diathesis, especially of immunological origin.
При внутримыщечном или внутривенном введении Эритрофосфатид не токсичен, не парогенен и не вызывает других побочных действий .When administered intramuscularly or intravenously, Erythrophosphatide is non-toxic, non-vaporogenic and does not cause other side effects.
Больные перенос т препарат хорощо.Patients tolerated the drug horoscho.
Он не вызывает местных и общих температурных реакций, быстро рассасываетс .It does not cause local and general temperature reactions, it quickly resolves.
При однократном введении препарата положительный эффект удерживаетс в течение 1-2 суток, дл закреплени его требуетс повторные введени .With a single administration of the drug, the positive effect is maintained for 1-2 days, and it is necessary to reintroduce it to fix it.
Экспериментальное и клиническое изучение эритрофосфатида показало его эффективность .An experimental and clinical study of erythrophosphatide has shown its effectiveness.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU1166638A SU552085A1 (en) | 1967-06-21 | 1967-06-21 | Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU1166638A SU552085A1 (en) | 1967-06-21 | 1967-06-21 | Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU552085A1 true SU552085A1 (en) | 1977-03-30 |
Family
ID=20440794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1166638A SU552085A1 (en) | 1967-06-21 | 1967-06-21 | Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU552085A1 (en) |
-
1967
- 1967-06-21 SU SU1166638A patent/SU552085A1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vollum et al. | Livedo reticularis during amantadine treatment | |
| SU552085A1 (en) | Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis | |
| HOEKENGA et al. | Jarisch-Herxheimer reaction in neurosyphilis treated with penicillin | |
| Coffey et al. | Ascorbic acid deficiency and aspirin-induced haematemesis. | |
| ANDRUS et al. | CORRECTION OF PROTHROMBIN DEFICIENCIES: BY MEANS OF 2-METHYL-1, 4-NAPHTHOQUINONE INJECTED INTRAMUSCULARLY | |
| EVERETT et al. | Intradermal Administration of Chloroquine: For Discoid Lupus Erythematosus and Lichen Sclerosus et Atrophicus | |
| KAMM | Control of sexual hyperactivity with thioridazine | |
| Scragg et al. | Emetine hydrochloride and chloroquine in the treatment of children with amoebic liver abscess. | |
| SU301951A1 (en) | MEDICINE | |
| COSTANTINO et al. | Toxic Epidermal Necrolysis: Two Cases in Children With a Review of the American Literature | |
| REIMANN et al. | Chloramphenicol in Paratyphoid A: Observations with a Note on the Clinical Aspects of the Disease | |
| Kendrick Jr et al. | Intra-Arterial Hypertonic Saline Solution in Experimental Shock | |
| Akuginova | Combination of antihelminthic drugs (phenasal and bithionole) for therapy of cestode inections. II. Investigation of the effectiveness of bithionole and of combination of bithionole with phenasal in treatment of taeniarhynchosis | |
| SU559703A1 (en) | Anabolic agent | |
| Blanton | Agranulocytosis with recovery | |
| Harley | Note on oral potassium chloride therapy in asthma, hay fever, urticaria, and eczema | |
| Alden et al. | Lupus erythematosus: a modification of therapy with gold compounds | |
| NEVINS | Anaphylactoid reaction following administration of one meprobamate tablet | |
| Guler et al. | Risperidone-induced maculopapular rash in a paediatric patient | |
| Gokhale | Treatment of trophic ulcers of the soles of the feet in leprosy with certain hydrogenated ergot alkaloids | |
| Yamamoto | Studies on Treatment of Wakana Disease I. Anchylostomocidal effects of various drugs against hookworm larvae | |
| SU133422A1 (en) | Medicinal product - rennet powder | |
| SU82331A1 (en) | Method of treating cattle theileriosis | |
| Alesen | Traumatic Shock and Hemorrhage | |
| Gregory et al. | Etamon studies in bronchial and cardiac asthma |